With success in overcoming blood cancers established, our current funding priorities focus on new curative strategies for the most difficult-to-treat solid tumor cancers – glioblastoma, a brain cancer, and pancreatic cancer. Every study, every clinical trial, every success and even every failure strengthens the research community’s understanding of the immune system’s complexities and the biological building blocks that make cancer such a formidable foe.
Search below to learn more about Alliance for Cancer Gene Therapy-funded researchers and their work to cure cancer.
